報價延遲最少15分鐘:2025/05/31 15:56 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
0.525 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.27/-1.56
|
|
企業價值
96.95M
|
| 資產負債 |
|
每股賬面淨值
2.79
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
6.59M
|
|
每股收益
0.05
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/05/31 15:56 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks. |